Transport deficiency is the molecular basis of \(Candida\) \(albicans\) resistance to antifungal oligopeptides

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Frontiers in Microbiology (2017) 8:2154. https://doi.org/10.3389/fmicb.2017.02154

Event: Veröffentlichung

(where): Würzburg

(who): Universität Würzburg

(when): 2021

Creator: Schielmann, Marta
Szweda, Piotr
Gucwa, Katarzyna
Kawczyński, Marcin
Milewska, Maria J.
Martynow, Dorota
Morschhäuser, Joachim
Milewski, Sławomir

DOI: 10.3389/fmicb.2017.02154

URN: urn:nbn:de:bvb:20-opus-173245

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Schielmann, Marta
Szweda, Piotr
Gucwa, Katarzyna
Kawczyński, Marcin
Milewska, Maria J.
Martynow, Dorota
Morschhäuser, Joachim
Milewski, Sławomir
Universität Würzburg

Time of origin

2021

Other Objects (12)

Candida albicans and Antifungal Peptides

Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

Antifungal activity of MAF-1A peptide against Candida albicans

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens

An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses

Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A

Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans

Candida albicans and Antifungal Peptides

Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

Antifungal activity of MAF-1A peptide against Candida albicans

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens

An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses

Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A

Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans

Candida albicans and Antifungal Peptides

Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

Antifungal activity of MAF-1A peptide against Candida albicans

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens

An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses

Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A

Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Transport deficiency is the molecular basis of \(Candida\) \(albicans\) resistance to antifungal oligopeptides

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Candida albicans and Antifungal Peptides

Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

Antifungal activity of MAF-1A peptide against Candida albicans

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens

An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses

Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A

Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans

Candida albicans and Antifungal Peptides

Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

Antifungal activity of MAF-1A peptide against Candida albicans

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens

An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses

Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A

Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans

Candida albicans and Antifungal Peptides

Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

Antifungal activity of MAF-1A peptide against Candida albicans

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens

An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses

Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A

Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment

The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans

Related objects

Reset password